Is Retinyl Palmitate safe in cosmetics?
Retinyl Palmitate has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 7 toxicological study endpoint(s) are available in our database.
Also known as: All-trans-retinyl palmitate, Vitamin A palmitate, BRN 1917366, EINECS 201-228-5, Vitamin A solubilized (+14 more)
INCI: RETINYL PALMITATE
Retinyl Palmitate (CAS 79-81-2) is a cosmetic active ingredient functioning as skin-conditioning, antioxidant. Reported NOAEL 1.2 mg/kg bw/day in rat (COSMOS_DB); EU Regulation 1223/2009 status: restricted, max 0.3%. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 79-81-2 →
Retinyl Palmitate is classified GHS Danger (H315, H360, H361, H413) in the chemicals database but is restricted in EU cosmetics at max 0.3%.
Source: Cosmetics: ingredients.eu_status/eu_max; Chemicals: ghs_classifications.signal_word/hazard_statement_code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Retinyl Palmitate.
Calculate MoS for your specific formulation with the MoS Calculator.
7 study endpoints found for Retinyl Palmitate. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 1.2 mg/kg bw/day | oral | rat | Chronic | COSMOS_DB |
| NOAEL | 1.4 mg/kg bw/day | oral | rat | Special Toxicology Study | COSMOS_DB |
| NOAEL | 4.09999990463 mg/kg bw/day | oral | primate | Developmental | COSMOS_DB |
| NOAEL | 5.5 mg/kg bw/day | oral | rat | Neurotoxicity | COSMOS_DB |
| NOAEL | 14 mg/kg bw/day | oral | dog | Chronic | COSMOS_DB |
| NOAEL | 24 mg/kg bw/day | oral | rat | Developmental | COSMOS_DB |
| NOAEL | =2.688 mg/kg bw/day | oral | Rat | subchronic | ToxValDB_ECHA_IUCLID |
Skin absorption and penetration characteristics of Retinyl Palmitate, relevant to systemic exposure and MoS calculations.
Source: SCCS/1378/10
9 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LD50 | >2000 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | =7910 mg/kg | Rat | oral | - | ECHA IUCLID |
| LOAEL | =10.368 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| LOAEL | =10.752 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =2.592 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =2.688 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOEL | <2.592 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| LD50 | =6060 mg/kg | Mouse | oral | - | ChemIDplus |
| LD50 | =7910 mg/kg | Rat | oral | - | ChemIDplus |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
agonist (RAR/RXR via conversion to retinol)
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | restricted | 0.3 | Face and body leave-on products |
| AU | restricted | 0.3 | anti-aging products |
| SA | restricted | 0.3 | Leave-on and rinse-off products |
| AE | restricted | 0.3 | Leave-on and rinse-off products |
| UK | restricted | - | - |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Face Cream | 0.1–1 | 2 | CIR/VCRP |
| Body Lotion | 0.1–1 | 2 | CIR/VCRP |
10 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Retinyl Palmitate.
Public NOAEL study rows linked to Retinyl Palmitate by CAS number or substance name.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Retinyl Palmitate has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 7 toxicological study endpoint(s) are available in our database.
Retinyl Palmitate EU regulatory status: restricted. Maximum allowed concentration: 0.3%. This is based on EU Regulation 1223/2009 and its amendments.
Retinyl Palmitate functions as: skin-conditioning, antioxidant. It is classified as a Active Ingredient in our database. CAS number: 79-81-2.
The NOAEL (No Observed Adverse Effect Level) for Retinyl Palmitate is 1.2 mg/kg bw/day based on a Chronic study via oral route in rat. A total of 7 study endpoints are available. Source: COSMOS_DB.
Retinyl Palmitate also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Retinyl Palmitate is classified GHS Danger (H315, H360, H361, H413) in the chemicals database but is restricted in EU cosmetics at max 0.3%.
Check Retinyl Palmitate compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Retinyl Palmitate in your formulation.